Dealing with health data exchange in a cross-border third country/EU context

The Conference is structured into four sessions, each focusing on key updates regarding the progress of the EU pharmaceutical package, providing perspectives from academia, public institutions, industry professionals, and other experts. The presentation of Oliver Brupbacher is part of a session that dives into the legal framework and concept of the European Health Data Space (EHDS), including cross-border implications of health data exchanges between Switzerland, the EU, the UK, the USA and other countries.